Do We Get Samples of the Report?

Yes, you will receive a sample copy of the market research report from the sales team when you put a query to us. The sample report is free and offers a brief view of the report and information on data available before you purchase the full-fledged report. Also, we will provide a demo sample for any oncoming study.

How to Buy a Market Report?

Select the report you wish to purchase and proceed to buy it by making an online payment. We use a secured gateway for payment transfers and do not share your financial information with any unconcerned third party.

In Which Format Will I Get the Report?

The report will be delivered in spreadsheet and PDF format. In some cases, PPT formats could be available as well.

In How Much Time I will Get the Report After Purchase?

After confirmation of the payment, you will receive the electronic format of the report at your registered email address in (mention the timeline for the delivery). If you buy a report over a holiday or weekend, we will process the request the next working day.

How Can I Get the Report Customized?

Market studies and reports already contain important data and are ready for distribution to the purchaser. However, if there is any particular query, addition, or customization you require, then contact us on our email id or phone. We will look to accommodate your request and see what can be done at the earliest. The research team will design the report accordingly and discuss the solutions beforehand with you.

How Much Will It Cost to Get a Report Customized?

The price of the customized report will be conveyed to you by our team after we agree on the deliverable. A delivery timeline will be set so that you get the report within the expected date. Any requests for customizations after selling the report will be handled by a separate department and the prices for the same mentioned upfront.

Can I Buy Only a Particular Segment of the Study?

While usually such a request is not accommodated as any market research report is wholesome and the cost of the report is for overall contents, in special cases, we may be able to sell select segments of the report based on your requirements.

Is There Any Available Discount?

Our team will love to support academicians, start-ups, students, and others with consulting and research. Thus, our pricing plan is based on keeping these interests in mind and is already affordable. However, we may have discounts available for particular customer types and reports. So, contact us for more information.

Which Services Are Complimentary Before Purchasing the Report?

We have consumer-centric reports and offer several facilities before selling. You will get a free review and sample report, talk to our customer care team for any additions to be done and meet special requirements, and interact with our analysts for deeper understanding.

Will I Receive a Bill or Invoice for the Report Purchased?

Yes, you will get an invoice for the purchase you made. The invoice will be sent to you electronically on your registered email id.

What If I am Unable to Find the Report in the Catalog?

We have a vast database of market reports and studies and there are a few which may not have been uploaded yet. If you are unable to find the one you want, then get in touch with our sales team by phone or email and we will connect with you for assistance.

How Often Are the Existing Studies Updated?

Not every study is the same. Thus, the update for reports will depend on the ongoing research and changes if any to be incorporated in the document or not.

What If the Report Does Not Contain the Information I Want?

The market research reports are constructed keeping in mind the industry trends, nature of the study, and required inputs. But if you want something more than what is stated in the report, we can help you out with further research if possible. Contact us right away, and we will do the needful to aid you.

Is the Payment Refundable?

Once the payment is done, it is non-refundable because as per the standard policy, the utility of the reports is based on knowledge sharing, and thus, a refund is not possible to make after we have issued you obtain the study. To avoid the hassle, we have a detailed view of the report and its ideas through a sample report.

What If the Payment Fails?

If the payment fails then be assured that you shall receive the money back to the source payment mode from the payment gateway. Aarkstore is not responsible for any loss of payment in the process.

Can I Avail the Report of a Particular Country/Region?

Yes, we can provide a report or segment related to a particular region or geography if we have that feature available for the document.

Do You Offer Support After Purchase?

Yes, we are here to solve any queries you may have for the report from our analyst till a given timeframe. To understand more about this, get in touch with us.

Global Vascular Stent Market: Analysis By Type (Coronary, Peripheral), Technology (Bare Metal, Drug Eluting, Bio-Resorbable), Mode of Delivery, End User, By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024) - By Mode of delivery (Self Expandable, Drug Eluting Expandable), By End User (Hospital, Ambulatory Surgical Centre), By Region (North America, Europe, Asia Pacific, ROW) and By Country (U.S., Canada, U.K., Germany, France, Italy, China, Japan, India, Brazil)

DESCRIPTION

TABLE OF CONTENTS

RELATED REPORTS

SAMPLE REQUEST

REVIEWS

DESCRIPTION

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of vascular stent market. The report analyses the Global Vascular Stent Market: Analysis By Type (Coronary, Peripheral), By Technology (Bare Metal, Drug Eluting, Bio-resorbable), By Mode of Delivery (Self- expandable, Balloon â€“expandable) and By End User (Hospital, Ambulatory Surgical Centre). The global vascular stent market has been analyzed By Region (North America, Europe, Asia Pacific, ROW) and By Country (U.S., Canada, U.K., Germany, France, Italy, China, Japan, India, Brazil) for the historical period of 2018-2019 and the forecast period of 2019-2024.

According to research report, the Vascular Stent market was valued at USD 7344.40 for the year 2018.

Over the recent years, Vascular Stent market has been witnessing considerable growth directly on the back of increasing prevalence of chronic diseases, rising demand for minimally invasive surgeries, and growing investment to develop highly advanced medical infrastructure. Moreover, factors such as growing government initiatives, growing aged population, and increasing prevalence of cardiovascular disease has been impelling the overall market growth of Vascular Stent. In addition, expanding product portfolio of companies and growing number of partnerships and acquisitions in this industry is anticipated to fuel the market growth in forecast period. However, stringent regulation process of the stents and occurrence of restenosis after stent implantation has been hindering the market growth.

The report titled report "Global Vascular Stent Market: Analysis By Type (Coronary, Peripheral), Technology (Bare Metal, Drug Eluting, Bio-Resorbable), Mode of Delivery, End User, By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024) - By Mode of delivery (Self Expandable, Drug Eluting Expandable), By End User (Hospital, Ambulatory Surgical Centre), By Region (North America, Europe, Asia Pacific, ROW) and By Country (U.S., Canada, U.K., Germany, France, Italy, China, Japan, India, Brazil)" has covered and analysed the potential of Vascular Stent market and provides statistics and information on market size, shares, market attractiveness and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities. Additionally, the report also highlights market entry strategies for various companies.

Scope of the Report

Global Vascular Stent Market (Actual Period: 2014-2018, Forecast Period: 2019-2024)
Vascular Stent Market- Size, Growth, Forecast
Analysis By Type: Coronary, Peripheral.
Analysis By Technology: Bare Metal, Drug Eluting, Bio-Resorbable
Analysis By Mode of Delivery: Self expandable, Balloon expandable
Analysis By End User: Hospital, Ambulatory Surgical Centre
Market Attractiveness of Global Vascular Stent Market- By Type, Technology, Mode of Delivery

Regional Vascular Stent Market - North America, Europe, Asia Pacific, ROW (Actual Period: 2014-2018, Forecast Period: 2019-2024)
Vascular Stent Market- Size, Growth, Forecast
Analysis By Type: Coronary, Peripheral.
Analysis By Technology: Bare Metal, Drug Eluting, Bio-Resorbable
Analysis By Mode of Delivery: Self expandable, Balloon expandable
Analysis By End User: Hospital, Ambulatory Surgical Centre
Market Attractiveness of Vascular Stent Market- By Country

Country Vascular Stent Market - U.S., Canada, Germany, U.K, France, Italy, China, Japan, India, and Brazil (Actual Period: 2014-2018, Forecast Period: 2019-2024)
Vascular Stent Market- Size, Growth, Forecast
Analysis By Type: Coronary, Peripheral.
Analysis By Technology: Bare Metal, Drug Eluting, Bio-Resorbable
Analysis By Mode of Delivery: Self expandable, Balloon expandable
Analysis By End User: Hospital, Ambulatory Surgical Centre

Other Report Highlights
Competitive Landscape
Company Share Analysis
Product Benchmarking
Pricing Analysis
Merger and Acquisitions of Key Industry Players
Most Recent Product Approvals and Pipeline Analysis
Market Dynamics - Drivers and Restraints.
Market Trends
Porter Five Forces Analysis
SWOT Analysis
Company Analysis - Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Medtronic, Terumo Corporation, B. Braun Melsungen, W.L. Gore & Associates, Cook Medical, Biotronik, Meril LifeSciences.

Customization of the Report
The report could be customized according to the clients specific research requirements. No additional cost will be required to pay for limited additional research.

TABLE OF CONTENTS

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Vascular Stent Market: Product Outlook

5. Global Vascular Stent Market: Growth and Forecast
5.1 By Value (2014-2018)
5.2 By Value (2019-2024)

6. Global Vascular Stent Market: Segment Analysis
6.1 Global Vascular Stent Market Size, By Type: Breakdown (%)
6.1.1 Global Vascular Stent Market Size, By Type, 2018 (%)
6.1.2 Global Vascular Stent Market Size, By Type, 2024 (%)
6.2 Global Coronary Vascular Stent Market, By Value (2014-2024)
6.3 Global Peripheral Vascular Stent Market, By Value (2014-2024)
6.4 Market attractiveness of Global Vascular Sent Market- By Type
6.5 Global Vascular Stent Market Size, By Technology: Breakdown (%)
6.5.1 Global Vascular Stent Market Size, By Technology, 2018 (%)
6.5.2 Global Vascular Stent Market Size, By Technology, 2024 (%)
6.6 Global Bare Metal Vascular Stent Market, By Value (2014-2024)
6.7 Global Drug Eluting Vascular Stent Market, By Value (2014-2024)
6.8 Global Bioresorbable Vascular Stent Market, By Value (2014-2024)
6.9 Market attractiveness of Global Vascular Sent Market- By Technology
6.10 Global Vascular Stent Market Size, By Mode of Delivery: Breakdown (%)
6.10.1 Global Vascular Stent Market Size, By Mode of Delivery, 2018 (%)
6.10.2 Global Vascular Stent Market Size, By Mode of Delivery, 2024 (%)
6.11 Global Self expandable Vascular Stent Market, By Value (2014-2024)
6.12 Global Balloon expandable Vascular Stent Market, By Value (2014-2024)
6.13 Market attractiveness of Global Vascular Sent Market- By Mode of Delivery
6.14 Global Vascular Stent Market Size, By End User: Breakdown (%)
6.14.1 Global Vascular Stent Market Size, By End User, 2018 (%)
6.14.2 Global Vascular Stent Market Size, By End User, 2024 (%)
6.15 Global Hospital Vascular Stent Market, By Value (2014-2024)
6.16 Global Ambulatory Surgical Centre Vascular Stent Market, By Value (2014-2024)
6.17 Market attractiveness of Global Vascular Sent Market- By End User

7. Global Vascular Stent Market: Regional Analysis
7.1 Global Vascular Stent Market Size, By Region: Breakdown (%)
7.1.1 Global Vascular Stent Market Size, By Region, 2018 (%)
7.1.2 Global Vascular Stent Market Size, By Region, 2024 (%)
7.2 North America Vascular Stent Market: Growth and Forecast
7.2.1 By Value (2014-2018)
7.2.2 By Value (2019-2024)
7.2.3 North America Vascular Stent Market: Competitive Landscape
7.2.4 By Type, By Value (2014-2018)
7.2.5 By Type, By Value (2019-2024)
7.2.6 By Technology, By Value (2014-2018)
7.2.7 By Technology, By Value (2019-2024)
7.2.8 By Mode of Delivery, By Value (2014-2018)
7.2.9 By Mode of Delivery, By Value (2019-2024)
7.2.10 By End User, By Value (2014-2018)
7.2.11 By End User, By Value (2019-2024)

7.3 Market Attractiveness of North America Vascular Stent Market- By Country

7.4 North America Vascular Stent Market: Country Analysis (U.S.A and Canada)
7.4.1 U.S.A Vascular Stent Market, By Value (2014-2024)
7.4.2 U.S.A Vascular Stent Market, By Type, By Value (2014-2018)
7.4.3 U.S.A Vascular Stent Market, By Type, By Value (2019-2024)
7.4.4 U.S.A Vascular Stent Market, By Technology, By Value (2014-2018)
7.4.5 U.S.A Vascular Stent Market, By Technology, By Value (2019-2024)
7.4.6 U.S.A Vascular Stent Market, By Mode of Delivery, By Value (2014-2018)
7.4.7 U.S.A Vascular Stent Market, By Mode of Delivery, By Value (2019-2024)
7.4.8 U.S.A Vascular Stent Market, By End User, By Value (2014-2018)
7.4.9 U.S.A Vascular Stent Market, By End User, By Value (2019-2024)
7.4.10 Canada Vascular Stent Market, By Value (2014-2024)
7.4.11 Canada Vascular Stent Market, By Type, By Value (2014-2018)
7.4.12 Canada Vascular Stent Market, By Type, By Value (2019-2024)
7.4.13 Canada Vascular Stent Market, By Technology, By Value (2014-2018)
7.4.14 Canada Vascular Stent Market, By Technology, By Value (2019-2024)
7.4.15 Canada Vascular Stent Market, By Mode of Delivery, By Value (2014-2018)
7.4.16 Canada Vascular Stent Market, By Mode of Delivery, By Value (2019-2024)
7.4.17 Canada Vascular Stent Market, By End User, By Value (2014-2018)
7.4.18 Canada Vascular Stent Market, By End User, By Value (2019-2024)

7.5 Europe Vascular Stent Market: Growth and Forecast
7.5.1 By Value (2014-2018)
7.5.2 By Value (2019-2024)
7.5.3 Europe Vascular Stent Market: Competitive Landscape
7.5.4 By Type, By Value (2014-2018)
7.5.5 By Type, By Value (2019-2024)
7.5.6 By Technology, By Value (2014-2018)
7.5.7 By Technology, By Value (2019-2024)
7.5.8 By Mode of Delivery, By Value (2014-2018)
7.5.9 By Mode of Delivery, By Value (2019-2024)
7.5.10 By End User, By Value (2014-2018)
7.5.11 By End User, By Value (2019-2024)

7.6 Market Attractiveness of Europe Vascular Stent Market: By Country

7.7 Europe Vascular Stent Market: Country Analysis (U.K, Germany)
7.7.1 U.K Vascular Stent Market, By Value (2014-2024)
7.7.2 U.K Vascular Stent Market, By Type, By Value (2014-2018)
7.7.3 U.K Vascular Stent Market, By Type, By Value (2019-2024)
7.7.4 U.K Vascular Stent Market, By Technology, By Value (2014-2018)
7.7.5 U.K Vascular Stent Market, By Technology, By Value (2014-2018)
7.7.6 U.K Vascular Stent Market, By Mode of Delivery, By Value (2014-2018)
7.7.7 U.K Vascular Stent Market, By Mode of Delivery, By Value (2014-2018)
7.7.8 U.K Vascular Stent Market, By End User, By Value (2014-2018)
7.7.9 U.K Vascular Stent Market, By End User, By Value (2014-2018)

7.5.10 Germany Vascular Stent Market, By Value (2014-2024)
7.5.11 Germany Vascular Stent Market, By Type, By Value (2014-2018)
7.5.12 Germany Vascular Stent Market, By Type, By Value (2019-2024)
7.5.13 Germany Vascular Stent Market, By Technology, By Value (2014-2018)
7.5.14 Germany Vascular Stent Market, By Technology, By Value (2019-2024)
7.5.15 Germany Vascular Stent Market, By Mode of Delivery, By Value (2014-2018)
7.5.16 Germany Vascular Stent Market, By Mode of Delivery, By Value (2019-2024)
7.5.17 Germany Vascular Stent Market, By End User, By Value (2014-2018)
7.5.18 Germany Vascular Stent Market, By User, By Value (2019-2024)

7.5.19 France Vascular Stent Market, By Value (2014-2024)
7.5.20 France Vascular Stent Market, By Type, By Value (2014-2018)
7.5.21 France Vascular Stent Market, By Type, By Value (2019-2024)
7.5.22 France Vascular Stent Market, By Technology, By Value (2014-2018)
7.5.23 France Vascular Stent Market, By Technology, By Value (2019-2024)
7.5.24 France Vascular Stent Market, By Mode of Delivery, By Value (2014-2018)
7.5.25 France Vascular Stent Market, By Mode of Delivery, By Value (2019-2024)
7.5.26 France Vascular Stent Market, By End User, By Value (2014-2018)
7.5.27 France Vascular Stent Market, By End User, By Value (2019-2024)

7.5.28 Italy Vascular Stent Market, By Value (2014-2024)
7.5.29 Italy Vascular Stent Market, By Type, By Value (2014-2018)
7.5.30 Italy Vascular Stent Market, By Type, By Value (2019-2024)
7.5.31 Italy Vascular Stent Market, By Technology, By Value (2014-2018)
7.5.32 Italy Vascular Stent Market, By Technology, By Value (2019-2024)
7.5.33 Italy Vascular Stent Market, By Mode of Delivery, By Value (2014-2018)
7.5.34 Italy Vascular Stent Market, By Mode of Delivery, By Value (2019-2024)
7.5.35 Italy Vascular Stent Market, By End User, By Value (2014-2018)
7.5.36 Italy Vascular Stent Market, By End User, By Value (2019-2024)

7.6 Asia Pacific (APAC) Vascular Stent Market: Growth and Forecast
7.6.1 By Value (2014-2018)
7.6.2 By Value (2019-2024)
7.6.3 APAC Vascular Stent Market: Competitive Landscape
7.6.4 By Type, By Value (2014-2018)
7.6.5 By Type, By Value (2019-2024)
7.6.6 By Technology, By Value (2014-2018)
7.6.7 By Technology, By Value (2019-2024)
7.6.8 By Mode of Delivery, By Value (2014-2018)
7.6.9 By Mode of Delivery, By Value (2019-2024)
7.6.10 By End User, By Value (2014-2018)
7.6.11 By End User, By Value (2019-2024)

7.7 Market Attractiveness of APAC Vascular Stent Market- By Country

7.8 APAC Vascular Stent Market: Country Analysis (Japan, India, China)
7.8.1 India Vascular Stent Market, By Value (2014-2024)
7.8.2 India Vascular Stent Market, By Type, By Value (2014-2018)
7.8.3 India Vascular Stent Market, By Type, By Value (2019-2024)
7.8.4 India Vascular Stent Market, By Technology, By Value (2014-2018)
7.8.5 India Vascular Stent Market, By Technology, By Value (2019-2024)
7.8.6 India Vascular Stent Market, By Mode of Delivery, By Value (2014-2018)
7.8.7 India Vascular Stent Market, By Mode of Delivery, By Value (2019-2024)
7.8.8 India Vascular Stent Market, By End User, By Value (2014-2018)
7.8.9 India Vascular Stent Market, By End User, By Value (2019-2024)

7.8.10 Japan Vascular Stent Market, By Value (2014-2024)
7.8.11 Japan Vascular Stent Market, By Type, By Value (2014-2018)
7.8.12 Japan Vascular Stent Market, By Type, By Value (2019-2024)
7.8.13 Japan Vascular Stent Market, By Technology, By Value (2014-2018)
7.8.14 Japan Vascular Stent Market, By Technology, By Value (2019-2024)
7.8.15 Japan Vascular Stent Market, By Mode of Delivery, By Value (2014-2018)
7.8.16 Japan Vascular Stent Market, By Mode of Delivery, By Value (2019-2024)
7.8.17 Japan Vascular Stent Market, By End User, By Value (2014-2018)
7.8.18 Japan Vascular Stent Market, By End User, By Value (2019-2024)

7.8.18 China Vascular Stent Market, By Value (2014-2024)
7.8.19 China Vascular Stent Market, By Type, By Value (2014-2018)
7.8.20 China Vascular Stent Market, By Technology, By Value (2014-2018)
7.8.21 China Vascular Stent Market, By Technology, By Value (2019-2024)
7.8.22 China Vascular Stent Market, By Mode of Delivery, By Value (2014-2018)
7.8.23 China Vascular Stent Market, By Mode of Delivery, By Value (2019-2024)
7.8.24 China Vascular Stent Market, By End User, By Value (2014-2018)
7.8.25 China Vascular Stent Market, By End User, By Value (2019-2024)

7.9 ROW Vascular Stent Market: Growth and Forecast
7.9.1 By Value (2014-2018)
7.9.2 By Value (2019-2024)
7.9.3 ROW Vascular Stent Market: Competitive Landscape
7.9.4 By Type, By Value (2014-2018)
7.9.5 By Type, By Value (2019-2024)
7.9.6 By Technology, By Value (2014-2018)
7.9.7 By Technology, By Value (2019-2024)
7.9.8 By Mode of Delivery, By Value (2014-2018)
7.9.9 By Mode of Delivery, By Value (2019-2024)
7.9.10 By End User, By Value (2014-2018)
7.9.11 By End User, By Value (2019-2024)

7.9.12 ROW Vascular Stent Market: Country Analysis -Brazil
7.9.13 Brazil Vascular Stent Market, By Value (2014-2024)
7.9.14 Brazil Vascular Stent Market, By Type, By Value (2014-2018)
7.9.15 Brazil Vascular Stent Market, By Type, By Value (2019-2024)
7.9.16 Brazil Vascular Stent Market, By Technology, By Value (2014-2018)
7.9.17 Brazil Vascular Stent Market, By Technology, By Value (2019-2024)
7.9.18 Brazil Vascular Stent Market, By Mode of Delivery, By Value (2014-2018)
7.9.19 Brazil Vascular Stent Market, By Mode of Delivery, By Value (2019-2024)
7.9.20 Brazil Vascular Stent Market, By End User, By Value (2014-2018)
7.9.21 Brazil Vascular Stent Market, By End User, By Value (2019-2024)

8. Global Vascular Stent Market: Competitive Landscape

9. Market share of Leading Global Companies

10. Global Vascular Stent Market: Pricing Analysis

11. Global Vascular Stent Market: Most Recent Products

12. Global Vascular Stent Market: Mergers and Acquisitions

13. Global Vascular Stent Market: Product Benchmarking

14. Global Vascular Stent Market Dynamics
14.1 Global Vascular Stent Market Drivers
14.1.1 Aging Society
14.1.2 Increasing awareness for minimally invasive procedures
14.1.3 Prevailing unhealthy lifestyle habits
14.1.4 Improved medical infrastructure and advantageous reimbursement opportunities
14.2 Global Vascular Stent Market Restraints
14.2.1 Stringent regulation process
14.2.2 Lack of reimbursement policies in developing nations
14.3 Global Vascular Stent Market Trend
14.3.1 Imminent drift towards bioresorbable stent
14.3.2 Growing outpatient service for minimally invasive procedures

15. Porter Five Force Analysis

16. SWOT Analysis

17. Supply Chain Analysis

18. Policy and Regulatory Landscape

19. Company Profiles
19.1 Abbott Laboratories
19.1.1 Business Overview
19.1.2 Financial Overview: Annual Sales & Annual Net Operating Income/Loss, Year 2014-2018
19.1.3 Segmental Overview: Sales Revenue â€“ By Geographic & Product Segment â€“ Year 2018
19.2 W.L. Gore & Associates
19.3 B. Braun Melsungen
19.3.1 Business Overview
19.3.2 Financial Overview: Annual Sales & Annual Net Operating Income/Loss, Year 2014-2018
19.3.3 Segmental Overview: Sales Revenue â€“ By Geographic & Product Segment â€“ Year 2018
19.4 Cook Medical
19.5 Boston Scientific Corporation
19.5.1 Business Overview
19.5.2 Financial Overview: Annual Sales & Annual Net Operating Income/Loss, Year 2014-2018
19.5.3 Segmental Overview: Sales Revenue â€“ By Geographic & Product Segment â€“ Year 2018
19.6 Cardinal Health
19.6.1 Business Overview
19.6.2 Financial Overview: Annual Sales & Annual Net Operating Income/Loss, Year 2014-2018
19.6.3 Segmental Overview: Sales Revenue â€“ By Product Segment â€“ Year 2018
19.7 Biotronik
19.8 Meril LifeSciences
19.9 Medtronic
19.9.1 Business Overview
19.9.2 Financial Overview: Annual Sales & Annual Net Operating Income/Loss, Year 2014-2018
19.9.3 Segmental Overview: Sales Revenue â€“ By Geographic & Product Segment â€“ Year 2018
19.10 Terumo Corporation
19.10.1 Business Overview
19.10.2 Financial Overview: Annual Sales & Annual Net Operating Income/Loss, Year 2014-2018
19.10.3 Segmental Overview: Sales Revenue â€“ By Geographic & Product Segment â€“ Year 2018

List Of Figures

List of Figures

Figure 1: Compounding Pharmacies, Flowchart
Figure 2: Typical Pharmacy Compounding Operations
Figure 3: Global Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 4: Global Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 5: Share of People Aged 65+, 2015 and 2050F (In %)
Figure 6: Distributions of persons aged 60 years or above by region in millions, 2015 and 2030F
Figure 7: Projected global population (In Billions)
Figure 8: Projected global population aged 60 years & above (In Billions)
Figure 9: Prevalence of Cardiovascular Diseases Worldwide (In million)
Figure 10: Number of people with diabetes, Worldwide, (In million), 2017 & 2045E
Figure 11: Key Facts & Figures About Diabetes, 2017
Figure 12: Projected increase in cases of diabetes in 2045, By region (In Percentage)
Figure 13: Top 10 countries for number of adults with diabetes (20-79 years), 2017, (In Million)
Figure 14: Global Burden of Cancer
Figure 15: Global Prevalence of Different Type of Cancer, 2017 (In Thousands)
Figure 16: Global Prevalence of Prostate Cancer (2013-2017, Thousands)
Figure 17: Global Expected Healthcare Industry Outlook
Figure 18: Regional Expected Healthcare Industry Growth Rate By Year 2020
Figure 19: Key Factors Driving Global Healthcare Industry
Figure 20: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %)
Figure 21: GDP Per Capita PPP, By Region, 2018 (in Thousand USD)
Figure 22: Global Compounding Pharmacies Market Size, By Product Type, By Value - 2018 (%)
Figure 23: Global Compounding Pharmacies Market Size, By Product Type, By Value - 2024F (%)
Figure 24: Global Compounding Pharmacies Market, By Oral Preparations, By Value, 2014-2018 (USD Million)
Figure 25: Global Compounding Pharmacies Market, By Oral Preparations, By Value, Forecast, 2019-2024 (USD Million)
Figure 26: Global Compounding Pharmacies Market, By Oral Preparations, By Value, 2014-2018 (USD Million)
Figure 27: Global Compounding Pharmacies Market, By Oral Preparations, By Value, Forecast, 2019-2024 (USD Million)
Figure 28: Global Compounding Pharmacies Market, By Ophthalmic Preparations, By Value, 2014-2018 (USD Million)
Figure 29: Global Compounding Pharmacies Market, By Ophthalmic Preparations, By Value, Forecast, 2019-2024 (USD Million)
Figure 30: Global Compounding Pharmacies Market, By Injectable Preparations, By Value, 2014-2018 (USD Million)
Figure 31: Global Compounding Pharmacies Market, By Injectable Preparations, By Value, Forecast, 2019-2024 (USD Million)
Figure 32: Global Compounding Pharmacies Market, By Other Preparations, By Value, 2014-2018, (USD Million)
Figure 33: Global Compounding Pharmacies Market, By Other Preparations, By Value, Forecast, 2019-2024 (USD Million)
Figure 34: Market Opportunity Chart of Global Compounding Pharmacies Market - By Product Type (Year-2024)
Figure 35: Global Compounding Pharmacies Market Size, By Therapeutic Area, By Value - 2018 (%)
Figure 36: Global Compounding Pharmacies Market Size, By Therapeutic Area, By Value - 2024F (%)
Figure 37: Global Compounding Pharmacies Market, By Hormone Replacement Application, By Value,2014-2018 (USD Million)
Figure 38: Global Compounding Pharmacies Market, By Hormone Replacement Application, By Value, Forecast, 2019-2024 (USD Million)
Figure 39: Global Compounding Pharmacies Market, By Pain Management Application, By Value, 2014-2018 (USD Million)
Figure 40: Global Compounding Pharmacies Market, By Pain Management Application, By Value, Forecast, 2019-2024 (USD Million)
Figure 41: Global Compounding Pharmacies Market, By Dermatology Application, By Value, 2014-2018 (USD Million)
Figure 42: Global Compounding Pharmacies Market, By Dermatology Application, By Value, Forecast, 2019-2024 (USD Million)
Figure 43: Global Compounding Pharmacies Market, By Other Therapeutic Areas, By Value, 2014-2018 (USD Million)
Figure 44: Global Compounding Pharmacies Market, By Other Therapeutic Areas, By Value, Forecast, 2019-2024 (USD Million)
Figure 45: Market Opportunity Chart of Global Compounding Pharmacies Market - By Therapeutic Area (Year-2024)
Figure 46: Global Compounding Pharmacies Market Size, By End User, By Value - 2018 (%)
Figure 47: Global Compounding Pharmacies Market Size, By End User, By Value - 2024F (%)
Figure 48: Global Compounding Pharmacies Market, By Adult End User, By Value, 2014-2018 (USD Million)
Figure 49: Global Compounding Pharmacies Market, By Adult End User, By Value, Forecast, 2019-2024 (USD Million)
Figure 50: Global Compounding Pharmacies Market, By Pediatric End User, By Value, 2014-2018 (USD Million)
Figure 51: Global Compounding Pharmacies Market, By Pediatric End User, By Value, Forecast, 2019-2024 (USD Million)
Figure 52: Global Compounding Pharmacies Market, By Geriatric End User, By Value, 2014-2018 (USD Million)
Figure 53: Global Compounding Pharmacies Market, By Geriatric End User, By Value, Forecast, 2019-2024 (USD Million)
Figure 54: Global Compounding Pharmacies Market, By Veterinary End User, By Value, 2014-2018 (USD Million)
Figure 55: Global Compounding Pharmacies Market, By Veterinary End User, By Value, Forecast, 2019-2024 (USD Million)
Figure 56: Market Opportunity Chart of Global Compounding Pharmacies Market - By End User (Year-2024)
Figure 57: Global Healthcare Landscape, By Select Region
Figure 58: Global Compounding Pharmacies Market Size, By Region, 2018 (%)
Figure 59: Global Compounding Pharmacies Market Size, By Region, 2024F (%)
Figure 60: North America Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 61: North America Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 62: North America GDP, 2012-2018 (USD Trillion)
Figure 63: North America GDP per capita, current prices, 2013-2023F (In USD)
Figure 64: North America, Adjusted net national income per capita, 2012-2017 (current USD)
Figure 65: North America Population above 65 year, 2015, 2030F, & 2050F (In Millions)
Figure 66: Prevalence of Diabetes in North America, 2017 & 2045E (In Million)
Figure 67: North America, Population Projections (In Millions)
Figure 68: Prevalence of Different Type of Cancer in North America in year 2016 & 2017 ( In Hundreds)
Figure 69: North America, Cancer Incidence (In Millions)
Figure 70: North America, Cancer Incidence, By Route of Administration, 2019E (In %)
Figure 71: Prevalence of Obesity in United States Among Populace Aged Above 20, 2013-2017 (% of total)
Figure 72: Prevalence of cardiovascular disease in North America, In million
Figure 73: North America, Company Share Analysis, 2018 (In %)
Figure 74: North America Compounding Pharmacies Market: By Product Type, By Value, 2014-2018 (USD Million)
Figure 75: North America Compounding Pharmacies Market: By Product Type, By Value, 2019E-2024F (USD Million)
Figure 76: North America Compounding Pharmacies Market: By Therapeutic Area, By Value, 2014-2018 (USD Million)
Figure 77: North America Compounding Pharmacies Market: By Therapeutic Area, By Value, 2019E-2024F (USD Million)
Figure 78: North America Compounding Pharmacies Market: By End User, By Value, 2014-2018 (USD Million)
Figure 79: North America Compounding Pharmacies Market: By End User, By Value, 2019E-2024F (USD Million)
Figure 80: Market Opportunity Chart of North America Compounding Pharmacies Market - By Country, By Value (Year-2024)
Figure 81: North America Compounding Pharmacies Market, Country Share, 2018 (%)
Figure 82: North America Compounding Pharmacies Market, Country Share, 2024F (%)
Figure 83: U.S. Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 84: U.S. Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 85: U.S., Population ages 65 and above, 2014-2018 (% of total)
Figure 86: Total national health expenditures, 2018
Figure 87: United States, GDP, 2012-2022F (In USD Billion)
Figure 88: U.S., Per Capita Expenditure on Healthcare, 2012-2018E (In USD)
Figure 89: United States, Number of Individuals Aged 65+, (In Million)
Figure 90: U.S, Population Projections (In Millions)
Figure 91: Canada Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 92: Canada Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 93: Canada, GDP, 2012-2022F (In USD Billion)
Figure 94: Canada, Health Care Spending, Key Facts, 2018
Figure 95: Canada, Population ages 65 and above, 2014-2018 (% of total)
Figure 96: Canada, Population Ageing Key Facts
Figure 97: Prevalence of Diabetics in Canada, (% of Total Population) 2015 & 2045F
Figure 98: Estimated Prevalence of Pre-Diabetics in Canada, (% of Total Population) 2015 & 2045F
Figure 99: Canada, Population Projections (In Millions)
Figure 100: Prevalence of Chronic Diseases Among Canadian Adults
Figure 101: Europe Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 102: Europe Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 103: European Country Population Aged 65 and Above, 2014-2018 (% of Total)
Figure 104: Euro Area, Population ages 65 years and above (% of total population), 2014-2018
Figure 105: Breakdown of Total Health Expenditure in Europe, 2018 (%)
Figure 106: Prevalence of Diabetes (Age 18+), 2017 & 2045E (In Million)
Figure 107: North America, Company Share Analysis, 2018 (In %)
Figure 108: Europe Compounding Pharmacies Market: By Product Type, By Value, 2014-2018 (USD Million)
Figure 109: Europe Compounding Pharmacies Market: By Product Type, By Value, 2019E-2024F (USD Million)
Figure 110: Europe Compounding Pharmacies Market: By Therapeutic Area, By Value, 2014-2018 (USD Million)
Figure 111: Europe Compounding Pharmacies Market: By Therapeutic Area, By Value, 2019E-2024F (USD Million)
Figure 112: Europe Compounding Pharmacies Market: By End User, By Value, 2014-2018 (USD Million)
Figure 113: Europe Compounding Pharmacies Market: By End User, By Value, 2019E-2024F (USD Million)
Figure 114: Market Opportunity Chart of Europe Compounding Pharmacies Market - By Country, By Value (Year-2024)
Figure 115: Europe Compounding Pharmacies Market, Country Share, 2018 (%)
Figure 116: Europe Compounding Pharmacies Market, Country Share, 2024F (%)
Figure 117: Germany Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 118: Germany Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 119: Germany, Current Expenditure on Health (All Functions) as a share of GDP, 2014-2018
Figure 120: Germany, Population ages 65 and above, 2012-2017 (% total)
Figure 121: Prevalence of Different Type of Cancer in Germany in year 2016 & 2017 ( In Hundreds)
Figure 122: U.K Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 123: U.K Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 124: Cancer Statistics in the United Kingdom
Figure 125: U.K, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Figure 126: Prevalence of cardiovascular diseases in United Kingdom, In million
Figure 127: U.K, Population Ages 65 and Above (% of total), 2012-2018
Figure 128: U.K, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Figure 129: APAC Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 130: APAC Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 131: Population ages 65 and above, APAC Region, 2018 (% of total)
Figure 132: Population ages 65 and above, APAC Region, By Select Country, 2050 (% of total)
Figure 133: APAC - Diabetes Prevalence (% of population ages 20 to 79), By Select Country, 2017
Figure 134: APAC - Obesity Rate, By Select Country, 2017 (In Percentage)
Figure 135: East Asia and Pacific, Share of urban population, 2013-2018 (In %)
Figure 136: Prevalence of cardiovascular diseases in APAC region, In million
Figure 137: APAC, Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 138: Estimated number of deaths from prostate cancer in 2012 and 2030
Figure 139: APAC Compounding Pharmacies Market: By Product Type, By Value, 2014-2018 (USD Million)
Figure 140: APAC Compounding Pharmacies Market: By Product Type, By Value, 2019E-2024F (USD Million)
Figure 141: APAC Compounding Pharmacies Market: By Therapeutic Area, By Value, 2014-2018 (USD Million)
Figure 142: APAC Compounding Pharmacies Market: By Therapeutic Area, By Value, 2019E-2024F (USD Million)
Figure 143: APAC Compounding Pharmacies Market: By End User, By Value, 2014-2018 (USD Million)
Figure 144: APAC Compounding Pharmacies Market: By End User, By Value, 2019E-2024F (USD Million)
Figure 145: Market Opportunity Chart of APAC Compounding Pharmacies Market - By Country, By Value (Year-2024)
Figure 146: APAC Compounding Pharmacies Market, Country Share, 2018 (%)
Figure 147: APAC Compounding Pharmacies Market, Country Share, 2024F (%)
Figure 148: India Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 149: India Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 150: India, Total Population, 2013-2023F (In Billion)
Figure 151: India, Share of Urban Population, 2012-2018 (In %)
Figure 152: India, GDP Growth Per Year, 2015-2019 (In %)
Figure 153: India, Total deaths due to cancer, 2018
Figure 154: Top 5 forms of cancer in men and women in India
Figure 155: Population ages 65 and above, 2013-2018 (% of total)
Figure 156: India, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Figure 157: China Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 158: China Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 159: China, GDP Growth Per Year, 2015-2019 (In %)
Figure 160: China, Total Population, 2013-2021F (In Billion)
Figure 161: China, Share of Urban Population, 2012-2018 (In %)
Figure 162: China, Adjusted net national income per capita (Current USD)
Figure 163: China, Population ages 65 and above, 2013-2018 (% of total)
Figure 164: Number of new cancer cases, Males (all ages), 2018 (In %)
Figure 165: Number of new cancer cases, Females(all ages), 2018 (In %)
Figure 166: Prevalence of Different Type of Cancer in China in year 2016 & 2017 ( In Hundreds)
Figure 167: China, Cancer Mortality Rate, By Cancer Site, 2018
Figure 168: Japan Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 169: Japan Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 170: Japan, Population ages 65 and above, 2012-2018 (% of total)
Figure 171: Japan, GDP Growth Per Year, 2015-2019F (In %)
Figure 172: Japan Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 173: Total Number of People With Cardiovascular Disorders in Japan, By Type, 2017 (In thousands)
Figure 174: Prevalence of Different Type of Cancer in Japan in year 2016 & 2017 ( In Hundreds)
Figure 175: ROW Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 176: ROW Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 177: North Africa and Middle East Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 178: Middle East and North Africa, GDP, 2012-2018 (In USD Trillion)
Figure 179: ROW, Population ages 60 or above, By Select Country, 2050F (% of total)
Figure 180: Population ages 65 and above, Middle East and North Africa Region, 2012-2018 (% of total)
Figure 181: Population ages 65 and above, Latin America and Caribbean Region, 2012-2018 (% of total)
Figure 182: Cancer Prevalence in MENA (% of total), 2018
Figure 183: Top 10 fastest growing economies, 2018, (In%)
Figure 184: Prevalence of Different Type of Cancer in Middle East and North Africa in year 2016 & 2017 ( In Hundreds)
Figure 185: Total Number of People With Cardiovascular Disorders in North Africa and Middle East, By Type, 2017 (In thousands)
Figure 186: ROW Compounding Pharmacies Market: By Product Type, By Value, 2014-2018 (USD Million)
Figure 187: ROW Compounding Pharmacies Market: By Product Type, By Value, 2019E-2024F (USD Million)
Figure 188: ROW Compounding Pharmacies Market: By Therapeutic Area, By Value, 2014-2018 (USD Million)
Figure 189: ROW Compounding Pharmacies Market: By Therapeutic Area, By Value, 2019E-2024F (USD Million)
Figure 190: ROW Compounding Pharmacies Market: By End User, By Value, 2014-2018 (USD Million)
Figure 191: ROW Compounding Pharmacies Market: By End User, By Value, 2019E-2024F (USD Million)
Figure 192: Market Opportunity Chart of ROW Compounding Pharmacies Market - By Country, By Value (Year-2024)
Figure 193: ROW Compounding Pharmacies Market, Country Share, 2018 (%)
Figure 194: ROW Compounding Pharmacies Market, Country Share, 2024F (%)
Figure 195: Brazil Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 196: Brazil Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 197: Brazil Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 198: Total Number of People With Cardiovascular Disorders in Brazil, By Type,2017 (In thousands)
Figure 199: Prevalence of Different Type of Cancer in Brazil in year 2016 & 2017 ( In Hundreds)
Figure 200: Prevalence of cardiovascular disease in Brazil, In Billion
Figure 201: Brazil health expenditure as a share of GDP, 2018
Figure 202: Brazil, Population ages 65 and above, 2012-2018 (In Percentage)
Figure 203: Mexico Compounding Pharmacies Market Size, By Value, 2014-2018 (USD Million)
Figure 204: Mexico Compounding Pharmacies Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 205: Key Drivers of Compounding Pharmacies Market in Mexico
Figure 206: Mexico, Compounding Pharmacies Market, Key Traits
Figure 207: Mexico, Population ages 65 and above, 2012-2018 (In Percentage)
Figure 208: FDA Compounding Inspection Activity, (As of June 2017)
Figure 209: Fagron, Business Verticals
Figure 210: Fagron, Revenue, 2014-2018 (In USD Million)
Figure 211: Fagron, Revenue, By Business Segment, 2018 (In %)
Figure 212: Fagron, Net Sales, By Geographic Region, 2018 (In %)
Figure 213: Doughertyâ€™s Pharmacy, Revenue, 2014-2018 (In USD Million)
Figure 214: Fresenius Kabi, Revenue, 2015-2018 (USD Billion)
Figure 215: Fresenius Kabi, By Product Group, 2018 (%)
Figure 216: Fresenius Kabi, By Region, 2018 (%)
Figure 217: Clinigen Group, Revenue, 2014-2018 (In USD Million)
Figure 218: Clinigen Group, Revenue, By Business Segment, 2018 (In %)
Figure 219: Clinigen Group, Adjusted Gross Profit, By Geographic Region, 2018 (In %)
Figure 220: Clinigen Group, Adjusted Gross Profit, By Client/Customer, 2018 (In %)
Figure 221: Harrow Health, Inc., Revenue, 2014-2018 (In USD Million)

List of Tables

Table A: Estimated number of people living with cancer, 2020F and 2030F
Table B: Global Access to Healthcare Index, Ranking of Select Countries in Asia Pacific Region, 2017 (score out of 10)
Table C: Prevailing risk factors for cardiovascular diseases across Brazil, In 2018
Table D: Healthcare spending pattern in Brazil (In USD)
Table E: Recent Company Acquisitions and Mergers in Compounding Pharmacies Market
Table F: Recent Company Acquisitions and Mergers in Compounding Pharmacies Market
Table G: Compounding Pharmacy Regulatory Requirements

RELATED REPORTS

SAMPLE REQUEST

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

REVIEWS

There is no Reviews available

Search and Get the Latest Market Research Reports

Global Biopsy Devices Market 2023

Global Veterinary Dermatology Drugs Market 2023

Global Vascular Ultrasound Machine Market Research Report

Global Vascular Ultrasound Machines Market Research Report

FAQs